pause button on blue background
Biotech

Capsida pauses phase 1 gene therapy trial after child dies

AbbVie, CRISPR Therapeutics and Eli Lilly have all struck deals with Capsida.
Nick Paul Taylor Sep 11, 2025 7:30am
Houses of Parliament with Big Ben and double-decker buses on Westminster bridge

Merck scraps £1B project, along with all R&D operations in UK

Sep 10, 2025 3:40pm
United Kingdom UK UK

ABPI releases life sci competition report as UK investment lags

Sep 10, 2025 5:30pm
patent infringement patent lawsuit

Arrowhead sues Ionis over patent dispute for Tryngolza rival

Sep 11, 2025 11:33am
scales of justice court legal law

FibroGen pays SEC $1.2M over claims of 'reverse engineered' data

Sep 11, 2025 10:41am
Network of blood vessels against a white background

Custom gene editor fixes mutation causing deadly disease in mice

Sep 11, 2025 1:48pm
More News

Exact Sciences rolls out Cancerguard multi-cancer blood test

Sep 11, 2025 1:00pm

LB Pharma upsizes IPO in 1st biotech listing since February

Sep 11, 2025 4:09am
Fierce Pharma

Editor's Corner—Summit must submit to Big Pharma, stat

Sep 10, 2025 2:50pm

IQVIA unveils AI suite for managing clinical trial finances

Sep 10, 2025 2:44pm